Recruiting
Phase 2

Phase 2a Study of VTX3232 in Parkinson's Disease

Sponsor:

Zomagen Biosciences Ltd.

Code:

NCT06556173

Conditions

Idiopathic Parkinson Disease

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

VTX3232

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-28. This information was provided to ClinicalTrials.gov by Zomagen Biosciences Ltd. on 2024-11-04.